Bueno, Héctor
Rossello, Xavier
Pocock, Stuart
Van de Werf, Frans
Chin, Chee Tang
Danchin, Nicolas
Lee, Stephen W-L
Medina, Jesús
Vega, Ana
Huo, Yong
Funding for this research was provided by:
AstraZeneca
Article History
Received: 25 January 2018
Accepted: 10 April 2018
First Online: 16 April 2018
Compliance with ethical standards
:
: H.B. has received consulting fees from Abbott, AstraZeneca, Bayer, BMS, Novartis and Pfizer; speaking fees from AstraZeneca, Bayer, BMS-Pfizer, Ferrer, Novartis, Servier and MEDSCAPE-the heart.org; and fees for research activities from AstraZeneca, BMS, Janssen, Novartis; S.P. has received research funding from AstraZeneca. F.v.d.W. has received consulting fees and research grants from Boehringer Ingelheim and Merck, and consulting fees from Roche, Sanofi-Aventis, AstraZeneca, and The Medicines Company. C.T.C. has received research support from Eli Lilly, honoraria from Medtronic, and has been a consultant or advisory board member for AstraZeneca. N.D. has received consulting or speaking fees from AstraZeneca, BMS, Boehringer-Ingelheim, GSK, MSD-Schering Plough, Novartis, Pierre Fabre, Pfizer, Roche, Sanofi-Aventis, Servier, Takeda, and The Medicines Company. J.M. and A.V. are employees of AstraZeneca. X.R., S.W-L.L. and Y.H. have nothing to disclose.